HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors

Clinical trial NCT05861895 · RECRUITING

Trial details

NCT number: NCT05861895
Sponsor: HighField Biopharmaceuticals Corporation
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors, Adult

Start date: 2023-12-12
Primary completion: 2027-06-23
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.